Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia
Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
07/07/2022 | Press release | Distributed by Public on 07/06/2022 18:36
Please select the service you want to use:
Smartlinks | Galaxy Gaming Inc. | News | Local News | Finance | Security Markets | Security Markets | Company News | Top Company News | Company Appointments | Corporate Officer Change | Financial Services | Investment Services | Arts and Culture | Casino and Gambling | Travel, Leisure and Recreation Industry | Public Companies | Gambling and Betting Companies | OTC Markets
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact